377 related articles for article (PubMed ID: 19415676)
1. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
2. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
3. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
4. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid.
Takarada T; Hinoi E; Kambe Y; Sahara K; Kurokawa S; Takahata Y; Yoneda Y
Eur J Pharmacol; 2007 Dec; 575(1-3):1-11. PubMed ID: 17698058
[TBL] [Abstract][Full Text] [Related]
6. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption.
Stern PH; Alvares K
J Cell Biochem; 2014 Nov; 115(11):2033-8. PubMed ID: 25042887
[TBL] [Abstract][Full Text] [Related]
8. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
Coetzee M; Haag M; Kruger MC
J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
[TBL] [Abstract][Full Text] [Related]
10. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
13. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
14. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
J Cell Biochem; 2005 Aug; 95(6):1224-34. PubMed ID: 15962303
[TBL] [Abstract][Full Text] [Related]
15. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
Jeong JC; Lee JW; Yoon CH; Kim HM; Kim CH
Toxicol In Vitro; 2004 Dec; 18(6):829-34. PubMed ID: 15465649
[TBL] [Abstract][Full Text] [Related]
16. Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells.
Satué M; Arriero Mdel M; Monjo M; Ramis JM
Biochem Pharmacol; 2013 Nov; 86(10):1476-86. PubMed ID: 24060614
[TBL] [Abstract][Full Text] [Related]
17. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
Kim JM; Min SK; Kim H; Kang HK; Jung SY; Lee SH; Choi Y; Roh S; Jeong D; Min BM
Int J Mol Med; 2007 Mar; 19(3):393-400. PubMed ID: 17273786
[TBL] [Abstract][Full Text] [Related]
18. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization of osteoblastic MC3T3-E1 cells.
Kim KW; Suh SJ; Lee TK; Ha KT; Kim JK; Kim KH; Kim DI; Jeon JH; Moon TC; Kim CH
J Ethnopharmacol; 2008 Jan; 115(1):42-9. PubMed ID: 17997241
[TBL] [Abstract][Full Text] [Related]
19. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
[TBL] [Abstract][Full Text] [Related]
20. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
